This is a Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency's Troop Support Medical division to Teva Pharmaceuticals USA, Inc., a foreign-owned pharmaceutical manufacturer, for the delivery of Adenovirus Type 4 vaccine. The $317,609.46 contract has an ultimate completion date of December 3, 2024 and is not set aside for any particular business type. Teva Pharmaceuticals is a major supplier of critical medical products, including vaccines, to various federal agencies such as the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, and Indian Health Service. In addition to this delivery order, Teva holds two significant Indefinite Delivery Contracts with the VA and DLA for the supply of glatiramer acetate injections and Levalbuterol HCL solution, respectively, demonstrating the company's important role in maintaining pharmaceutical supplies for federal healthcare programs.
Generated 2/19/25, 9:26 AM